Pharmaceutical composition containing at least one Compound with activity of CB1 receptor, or a prodrug, tautomero or Salt thereof as active Component suitable for the prophylaxis and / or treatment of diseases associated with CB1 receptor in Youth patients for Treatment and / or / and

摘要

Compounds with Therapeutic use of Cannabis receptor antagonist activity of CB - 1, elected Group of Derivatives of 4,5-dihydro - 1H - 1H pyrazole Derivatives, imidazole, thiazole Derivatives and7or Derivatives of 1,2,4-triazole - 1H - 3 - carboxamide, or a prodrug, tautu00f3mero or Salt thereof,In the preparation of drugs for the prophylaxis and / or treatment of related diseases in patients receiving CB, Juvenile and / or for the prophylaxis and / or treatment of Obesity induced by drug in patients as a Youth and adolescents. Use of these compounds with CB receptor activity in combination with Lipase inhibitors.These compounds are particularly suitable in combination with Lipase inhibitors in the preparation of drugs for the prophylaxis and / or treatment of obesity in Adolescents OR Juvenile and / or for the Treatment or prophylaxis of Obesity patients induced by drugs in J Uveniles as well as adolescents.Lipase inhibitors are preferred panclicinas ATL - 952, orlistat, and / or lipstatina.